Skip to main content
logo
Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.780
-0.070 (-3.78%)
Aug 28, 2026, 3:26 PM EDT - Market open

Gain Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-20.11-20.16-20.41-22.27-17.59-13.89
Depreciation & Amortization
0.050.050.040.040.030.02
Other Amortization
0.050.050.050.050.04-
Stock-Based Compensation
1.831.82.393.261.530.84
Other Operating Activities
0.350.80.14-0.38-0.211
Change in Accounts Receivable
-----0.01
Change in Accounts Payable
-1.69-0.470.27-0.691.07-0.52
Change in Unearned Revenue
-0.01-0.33-0.851.09-0.210.03
Change in Other Net Operating Assets
0.57-0.21-0.50.050.660.15
Operating Cash Flow
-18.95-18.47-18.87-18.87-14.69-12.37
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
---0.02-0.02-0.12-0.09
Investment in Securities
--510.24-14.66-
Investing Cash Flow
--4.9810.22-14.77-0.09

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.1-0.09-0.09-0.08-0.02
Net Debt Issued (Repaid)
-0.1-0.1-0.09-0.09-0.08-0.02
Issuance of Common Stock
25.8528.9413.3812.73-42.64
Other Financing Activities
-0.4-0.4-0.28---0.85
Financing Cash Flow
25.3528.4513.0112.64-0.0841.77

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.010.47-0.530.49-0.020.1
Net Cash Flow
6.3910.46-1.414.49-29.5729.41

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-18.95-18.47-18.9-18.88-14.81-12.46
Free Cash Flow Growth
------
Free Cash Flow Margin
----34217.53%-11166.38%-9303.42%
Free Cash Flow Per Share
-0.48-0.56-0.83-1.45-1.25-1.23
Levered Free Cash Flow
-11.14-10.5-11.47-9.8-8.2-6.97
Unlevered Free Cash Flow
-11.14-10.5-11.47-9.8-8.2-6.97

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
0.050.050.090.1300
Change in Working Capital
-1.13-1.01-1.080.441.51-0.33
SEC Filings: 10-K · 10-Q